The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...
Robert F. Kennedy Jr., President Trump's nominee to lead HHS, spoke highly of GLP-1 drugs at a Senate confirmation hearing ...
Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 Agonists
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Novo Nordisk’s NVO amycretin, which targets GLP-1 and amylin in one molecule, generated 24% placebo-adjusted weight loss in a ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Oprah Winfrey has been slammed for her controversial comments about 'thin people' while discussing her use of weight loss ...
THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback